October 23, 2018
Mayo Clinic research is bringing together knowledge of psychiatry, genetics, metabolomics, pharmacogenomics and artificial intelligence to seek biological markers associated with alcohol use disorder and treatment response. Finding the molecular drivers of alcohol use disorder commonly known as alcoholism, could help predict who is most likely to develop this disorder and who might respond to […]
Tags: Alcohol use disorder, Alcoholism, Alcoholism Recovery, Dr. Richard Weinshilboum, Dr. Victor Karpyak, Hazelden Betty Ford Foundation, Mayo Clinic Center for Individualized Medicine